title: Adolescent Vaccination Performance in South Carolina Compared to the United States.
abstract: National data on vaccine up-to-date (UTD) suggest that insufficient numbers of adolescents receive needed vaccines. This study analyzed public use data of the National Immunization Survey-Teen (NIS-Teen) from 2010 through 2013 for South Carolina (SC) adolescents and compared immunization rates to those of United States (US) adolescents. We also examined trends for each vaccine recommended for adolescents for both SC and US adolescents. UTD rates in SC adolescents for the quadrivalent meningococcal conjugate vaccine (MCV4) and the tetanus- diphtheria, acellular pertussis (Tdap) vaccine lag those of US adolescents, despite demonstrating a trend of improvement in SC adolescents from 45% to 69% for MCV and from 48% to 72% for Tdap. Human papillomavirus (HPV) vaccine UTD rates for SC adolescents demonstrated improvement over a 4 year period. HPV vaccination for SC girls improved when compared to the US, however UTD rates for both the SC and US were still well below the Healthy People 2020 goal of 80%. For all three vaccines, parental recall for a provider recommendation to vaccinate their adolescent was around or below 50%, except for HPV in females where it reached 65% in SC and 69% in the US. Differences between state and national rates may help SC providers focus on specific interventions needed to improve UTD rates.
authors.forename: James R
authors.initials: JR
authors.lastname: Roberts
authors.forename: Monique
authors.initials: M
authors.lastname: Naifeh
authors.forename: Robert M
authors.initials: RM
authors.lastname: Jacobson
authors.forename: Erin
authors.initials: E
authors.lastname: Hinton
authors.forename: Elizabeth
authors.initials: E
authors.lastname: O'Brien
authors.forename: Brianna
authors.initials: B
authors.lastname: Rogacki
authors.forename: David
authors.initials: D
authors.lastname: Thompson
authors.forename: Benyamin
authors.initials: B
authors.lastname: Margolis
authors.forename: Paul M
authors.initials: PM
authors.lastname: Darden
mesh_terms: D000293:Adolescent; D016208:Databases, Factual; D004165:Diphtheria / Q000517:prevention & control*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007114:Immunization / Q000706:statistics & numerical data*; D008297:Male; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000627:therapeutic use*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D011203:Poverty / Q000706:statistics & numerical data; D013022:South Carolina; D013742:Tetanus / Q000517:prevention & control*; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014917:Whooping Cough / Q000517:prevention & control*
chemical_list: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines